BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Canadian Pulmonary Fibrosis Foundation - ECPv6.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://cpff.ca
X-WR-CALDESC:Events for Canadian Pulmonary Fibrosis Foundation
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240903T130000
DTEND;TZID=America/Toronto:20240903T140000
DTSTAMP:20240819T210615Z
CREATED:20240819T210155Z
LAST-MODIFIED:20240819T210615Z
UID:10001222-1725368400-1725372000@cpff.ca
SUMMARY:BEACON-IPF Clinical Trial Overview: Investigating the slowing or halting of idiopathic pulmonary fibrosis
DESCRIPTION:Get an overview of Pliant Therapeutics BEACON-IPF global clinical trial which aims to find out whether bexotegrast slows down or halts idiopathic pulmonary fibrosis disease progression over a 52-week treatment period by reducing scar formation (fibrosis) of the lungs. \n\n\n\nLearn about previous clinical trial results\, how to participate if you have idiopathic pulmonary fibrosis\, and what to expect.
URL:https://cpff.ca/event/beacon-ipf-clinical-trial-overview-investigating-the-slowing-or-halting-of-idiopathic-pulmonary-fibrosis/
CATEGORIES:Educational Forums
ATTACH;FMTTYPE=image/jpeg:https://cpff.ca/wp-content/uploads/2024/08/Pliant-Therapeutics-BEACON-IPF-Clinical-Trial-Overview-Webinar.jpg
END:VEVENT
END:VCALENDAR